{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:04:27Z","timestamp":1792461867405,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":1251,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA203348"],"award-info":[{"award-number":["R01 CA203348"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA77598"],"award-info":[{"award-number":["P30 CA77598"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1074\/jbc.m116.746859","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T01:10:22Z","timestamp":1487898622000},"page":"6339-6351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17"],"prefix":"10.1016","volume":"292","author":[{"given":"Petra C.","family":"Buchanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.M.","family":"Boylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Walcheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Argenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P.N.","family":"Skubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.746859_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin"},{"key":"10.1074\/jbc.M116.746859_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It's totally tubular: riding the new wave of ovarian cancer research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.746859_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M116.746859_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol. Oncol"},{"key":"10.1074\/jbc.M116.746859_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Burleson","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1074\/jbc.M116.746859_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-5876-4-6","article-title":"Disaggregation and invasion of ovarian carcinoma ascites spheroids","volume":"4","author":"Burleson","year":"2006","journal-title":"J. Transl. Med"},{"key":"10.1074\/jbc.M116.746859_bib7","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","article-title":"Enfortumab vedotin antibody-drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models","volume":"76","author":"Challita-Eid","year":"2016","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.746859_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9440(10)63306-8","article-title":"Differential gene expression in ovarian carcinoma: identification of potential biomarkers","volume":"165","author":"Hibbs","year":"2004","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M116.746859_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker","volume":"134","author":"Derycke","year":"2010","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1074\/jbc.M116.746859_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/1354750X.2014.940503","article-title":"The diagnostic efficacy of nectin 4 expression in ovarian cancer patients","volume":"19","author":"Nabih","year":"2014","journal-title":"Biomarkers"},{"key":"10.1074\/jbc.M116.746859_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-015-0144-7","article-title":"Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer","volume":"34","author":"Nishiwada","year":"2015","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1074\/jbc.M116.746859_bib12","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1038\/oncsis.2014.32","article-title":"Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer","volume":"3","author":"Lattanzio","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1074\/jbc.M116.746859_bib13","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","article-title":"Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer","volume":"69","author":"Takano","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.746859_bib14","doi-asserted-by":"crossref","first-page":"36297","DOI":"10.1074\/jbc.M111.261768","article-title":"Cooperative role of nectin-nectin and nectin-afadin interactions in formation of nectin-based cell-cell adhesion","volume":"286","author":"Kurita","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.746859_bib15","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.18632\/oncotarget.14206","article-title":"The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate","volume":"8","author":"Boylan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.M116.746859_bib16","doi-asserted-by":"crossref","first-page":"e00358","DOI":"10.7554\/eLife.00358","article-title":"A role for PVRL4-driven cell-cell interactions in tumorigenesis","volume":"2","author":"Pavlova","year":"2013","journal-title":"Elife"},{"key":"10.1074\/jbc.M116.746859_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(07)65001-3","article-title":"Cross-talk among integrin, cadherin, and growth factor receptor: roles of nectin and nectin-like molecule","volume":"265","author":"Ogita","year":"2008","journal-title":"Int. Rev. Cytol"},{"key":"10.1074\/jbc.M116.746859_bib18","doi-asserted-by":"crossref","first-page":"19543","DOI":"10.1074\/jbc.M410943200","article-title":"Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-\u03b1-converting enzyme (TACE)\/ADAM-17","volume":"280","author":"Fabre-Lafay","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.746859_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-7-73","article-title":"Nectin-4 is a new histological and serological tumor associated marker for breast cancer","volume":"7","author":"Fabre-Lafay","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.M116.746859_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/15384047.2016.1177684","article-title":"The ADAMs family of proteases as targets for the treatment of cancer","volume":"17","author":"Mullooly","year":"2016","journal-title":"Cancer Biol. Ther"},{"key":"10.1074\/jbc.M116.746859_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1101\/gad.1039703","article-title":"The ADAMs family of metalloproteases: multidomain proteins with multiple functions","volume":"17","author":"Seals","year":"2003","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M116.746859_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1091\/mbc.e06-01-0014","article-title":"Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx","volume":"18","author":"Horiuchi","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M116.746859_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200310024","article-title":"Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation","volume":"165","author":"Nagano","year":"2004","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M116.746859_bib24","doi-asserted-by":"crossref","first-page":"42898","DOI":"10.1074\/jbc.M403193200","article-title":"Evaluation of the contribution of different ADAMs to tumor necrosis factor \u03b1 (TNF\u03b1) shedding and of the function of the TNF\u03b1 ectodomain in ensuring selective stimulated shedding by the TNF\u03b1 convertase (TACE\/ADAM17)","volume":"279","author":"Zheng","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.746859_bib25","doi-asserted-by":"crossref","first-page":"e0121788","DOI":"10.1371\/journal.pone.0121788","article-title":"Identification of an ADAM17 cleavage region in human CD16 (Fc\u03b3RIII) and the engineering of a non-cleavable version of the receptor in NK cells","volume":"10","author":"Jing","year":"2015","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M116.746859_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.2015.288","article-title":"ADAM10: a new player in breast cancer progression?","volume":"113","author":"Mullooly","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M116.746859_bib27","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/or.2013.2650","article-title":"ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells","volume":"30","author":"Yuan","year":"2013","journal-title":"Oncol. Rep"},{"key":"10.1074\/jbc.M116.746859_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/annonc\/mdm609","article-title":"ADAM-17 predicts adverse outcome in patients with breast cancer","volume":"19","author":"McGowan","year":"2008","journal-title":"Ann. Oncol"},{"key":"10.1074\/jbc.M116.746859_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gyorffy","year":"2012","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/jbc.M116.746859_bib30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1091\/mbc.e08-11-1135","article-title":"ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor \u03b1, l-selectin, and tumor necrosis factor \u03b1","volume":"20","author":"Le Gall","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M116.746859_bib31","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1016\/S0960-894X(98)00597-6","article-title":"Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors","volume":"8","author":"Sheppard","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.M116.746859_bib32","doi-asserted-by":"crossref","first-page":"8781","DOI":"10.1016\/j.bmc.2008.08.058","article-title":"Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge","volume":"16","author":"Georgiadis","year":"2008","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.M116.746859_bib33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bmcl.2008.01.075","article-title":"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-\u03b1 converting enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1\u2032 substituents","volume":"18","author":"Ott","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.M116.746859_bib34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbamcr.2012.11.027","article-title":"ADAM17 cleaves CD16b (Fc\u03b3RIIIb) in human neutrophils","volume":"1833","author":"Wang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M116.746859_bib35","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1073\/pnas.1017067108","article-title":"Cross-domain inhibition of TACE ectodomain","volume":"108","author":"Tape","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.746859_bib36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood-2002-12-3775","article-title":"The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion","volume":"102","author":"Hundhausen","year":"2003","journal-title":"Blood"},{"key":"10.1074\/jbc.M116.746859_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.M116.746859_bib38","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.M116.746859_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.746859_bib40","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.0802770","article-title":"Regulation of mature ADAM17 by redox agents for l-selectin shedding","volume":"182","author":"Wang","year":"2009","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M116.746859_bib41","doi-asserted-by":"crossref","first-page":"38980","DOI":"10.1074\/jbc.M111.277087","article-title":"Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.746859_bib42","doi-asserted-by":"crossref","first-page":"e17489","DOI":"10.1371\/journal.pone.0017489","article-title":"TACE\/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells","volume":"6","author":"Lemjabbar-Alaoui","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M116.746859_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1167\/iovs.08-2246","article-title":"ERK1\/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding","volume":"50","author":"Yin","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.M116.746859_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2012.05.057","article-title":"siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line","volume":"521","author":"Hurst","year":"2012","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M116.746859_bib45","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.746859_bib46","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jog.12806","article-title":"Diagnostic value of plasma lysophosphatidic acid levels in ovarian cancer patients: A case-control study and updated meta-analysis","volume":"41","author":"Cao","year":"2015","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1074\/jbc.M116.746859_bib47","doi-asserted-by":"crossref","first-page":"24588","DOI":"10.1074\/jbc.272.39.24588","article-title":"Identification and characterization of a pro-tumor necrosis factor-\u03b1-processing enzyme from the ADAM family of zinc metalloproteases","volume":"272","author":"Rosendahl","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.746859_bib48","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1073\/pnas.95.7.3408","article-title":"Crystal structure of the catalytic domain of human tumor necrosis factor-\u03b1-converting enzyme","volume":"95","author":"Maskos","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.746859_bib49","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1242\/jcs.069997","article-title":"ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site","volume":"123","author":"Le Gall","year":"2010","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.M116.746859_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0092-8674(00)80519-X","article-title":"Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF \u03b1 and Notch","volume":"90","author":"Blobel","year":"1997","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.746859_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2005.08.014","article-title":"Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans","volume":"123","author":"Janes","year":"2005","journal-title":"Cell"},{"key":"10.1074\/jbc.M116.746859_bib52","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0955-0674(00)00139-3","article-title":"Remarkable roles of proteolysis on and beyond the cell surface","volume":"12","author":"Blobel","year":"2000","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1074\/jbc.M116.746859_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrm1548","article-title":"ADAMs: key components in EGFR signalling and development","volume":"6","author":"Blobel","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M116.746859_bib54","doi-asserted-by":"crossref","first-page":"35067","DOI":"10.1038\/srep35067","article-title":"Control of ADAM17 activity by regulation of its cellular localisation","volume":"6","author":"Lorenzen","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.M116.746859_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jprot.2016.05.005","article-title":"A proteomic signature of ovarian cancer tumor fluid identified by high-throughput and verified by targeted proteomics","volume":"145","author":"Poersch","year":"2016","journal-title":"J. Proteomics"},{"key":"10.1074\/jbc.M116.746859_bib56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M116.746859_bib57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng.3573","article-title":"Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer","volume":"48","author":"McPherson","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M116.746859_bib58","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/mol.62.3.660","article-title":"Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific","volume":"62","author":"Baudhuin","year":"2002","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M116.746859_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.29385","article-title":"Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms","volume":"137","author":"Matte","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M116.746859_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M116.746859_bib61","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","article-title":"Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2032 kinase\/AKT pathways","volume":"24","author":"Larue","year":"2005","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M116.746859_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1559-0275-8-9","article-title":"The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?","volume":"8","author":"Duffy","year":"2011","journal-title":"Clin. Proteomics"},{"key":"10.1074\/jbc.M116.746859_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2008.01.012","article-title":"New therapies for ovarian cancer: cytotoxics and molecularly targeted agents","volume":"67","author":"Dinh","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"10.1074\/jbc.M116.746859_bib64","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/bjc.2013.529","article-title":"Targeting EGFR and PI3K pathways in ovarian cancer","volume":"109","author":"Glaysher","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M116.746859_bib65","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2013-09-511543","article-title":"Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space","volume":"123","author":"Pruessmeyer","year":"2014","journal-title":"Blood"},{"key":"10.1074\/jbc.M116.746859_bib66","doi-asserted-by":"crossref","first-page":"32810","DOI":"10.18632\/oncotarget.9053","article-title":"Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease","volume":"7","author":"Haley","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.M116.746859_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.3HI0714-340R","article-title":"Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17)","volume":"97","author":"Mishra","year":"2015","journal-title":"J. Leukoc. Biol"},{"key":"10.1074\/jbc.M116.746859_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820449671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820449671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.746859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T14:06:27Z","timestamp":1641305187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820449671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":68,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0021925820449671"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.746859","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.746859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}